Loading…
The patent pertains to the company's innovative medical device technology.
Autonomix Medical, Inc. (Nasdaq: AMIX) announced on July 23, 2026, that it has been granted a patent by the relevant authorities. The patent is for a novel medical device technology developed by the company.
The granted patent enhances Autonomix Medical's intellectual property portfolio, providing a competitive edge in the medical devices industry. The company's free float stands at 526,438 shares.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.